Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,426 | -21,026 | -10,315 | -31,242 | -18,498 |
| Depreciation Amortization | 1,839 | 1,091 | 497 | 994 | 598 |
| Accounts receivable | 1,890 | 197 | -1,787 | -1,717 | 920 |
| Accounts payable and accrued liabilities | -1,172 | 330 | 2,737 | 1,682 | 3,021 |
| Other Working Capital | 2,020 | 265 | -1,851 | -3,896 | -992 |
| Other Operating Activity | 3,768 | 2,808 | 837 | 115 | -5,467 |
| Operating Cash Flow | $-27,081 | $-16,335 | $-9,882 | $-34,064 | $-20,418 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,667 | 13,418 | 11,004 | -13,695 | -12,688 |
| PPE Investments | -11,323 | -9,425 | -5,044 | -3,925 | -2,222 |
| Investing Cash Flow | $2,344 | $3,993 | $5,960 | $-17,620 | $-14,910 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 14,383 | 14,308 | N/A | 13,109 | 13,109 |
| Debt Repayment | -5,703 | -5,043 | -136 | -12,542 | -12,409 |
| Common Stock Issued | 41,299 | 41,137 | 901 | 56,380 | 56,211 |
| Other Financing Activity | -3,416 | -4,885 | 0 | 9,186 | 9,186 |
| Financing Cash Flow | $46,563 | $45,517 | $765 | $66,133 | $66,097 |
| Beginning Cash Position | 24,455 | 24,455 | 24,455 | 10,006 | 10,006 |
| End Cash Position | 46,281 | 57,630 | 21,298 | 24,455 | 40,775 |
| Net Cash Flow | $21,826 | $33,175 | $-3,157 | $14,449 | $30,769 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,081 | -16,335 | -9,882 | -34,064 | -20,418 |
| Capital Expenditure | -11,329 | -9,425 | -5,044 | -3,966 | -2,238 |
| Free Cash Flow | -38,410 | -25,760 | -14,926 | -38,030 | -22,656 |